Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trialArticle Published on 2022-11-012022-11-15 Journal: Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% confidence interval Administered adverse event approved assessment booster booster dose booster vaccination clinical trials Course COVID-19 COVID-19 vaccination COVID-19 vaccine cross-neutralization cross-neutralization. Day double-blind Effect fatigue Heterologous homologous humoral immunogenic immunogenicity incidence injection site pain Local Neutralizing antibodies neutralizing antibody outcome participant Participants Placebo placebo-controlled primary immunogenicity Randomized randomized placebo-controlled trial Recombinant spike protein reported robust Safe Safety safety profile saline placebo SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variants Serious Adverse Event Serious Adverse Events Seroconversion seroconversion rate shown SpikoGen subunit the placebo group Trial Vaccine was performed [DOI] 10.1111/imm.13540 PMC 바로가기
Hormonal trends in patients suffering from long COVID symptomsArticle Published on 2022-10-282023-07-09 Journal: Endocrine journal [Category] COVID19(2023년), [키워드] fatigue growth hormone Hypothalamo-pituitary-adrenal (HPA) axis Long COVID Thyroid [DOI] 10.1507/endocrj.EJ22-0093
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndromeArticle Published on 2022-10-202022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] analyzed Anti-viral anti-viral antibody antibody Antibody Response baseline chronic disease CMV cohorts COVID-19 EBV elevated fatigue healthy donor herpesvirus herpesvirus reactivation HERV HERV-K HHV6A HSV2 IgG immunoassay latent virus majority ME/CFS mechanisms multiplex Myalgic encephalomyelitis/chronic fatigue syndrome nuclear oral mucosa overlap Patient plasma Post-viral fatigue Reactivation retrovirus risk factor Saliva SARS-COV-2 infection shown significantly sustained Symptom syndrome systemically triggered unique viral infection virus [DOI] 10.3389/fimmu.2022.949787 PMC 바로가기
Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trialArticle Published on 2022-10-182022-11-15 Journal: Nature Communications [Category] 치료제, [키워드] 95% CI benefit confidence interval COVID-19 COVID-19 infection Effect Evidence fatigue Finnish Follow-up Hospitalization hospitalized patients hospitals joint long-COVID Long-term follow-up memory occurred outcome Pain Patient Primary outcome problem Quality of life Randomized randomized trial recruited Remdesivir reported resulting SOC Standard of care survived Symptom Symptoms Trial [DOI] 10.1038/s41467-022-33825-5 PMC 바로가기
Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID SyndromeArticle Published on 2022-10-162023-07-10 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), [키워드] Cognition COVID-19 Depression fatigue occupational status post-COVID syndrome [DOI] 10.3390/ijerph192013368 PMC 바로가기
Respondent Fatigue Reduces Dietary Diversity Scores Reported from Mobile Phone Surveys in Ethiopia during the COVID-19 PandemicArticle Published on 2022-10-062022-11-16 Journal: The Journal of Nutrition [Category] 비임상, [키워드] assigned collected comparison country COVID-19 COVID-19 pandemic decrease dietary dietary diversity Diversity Effect Ethiopia Ethiopian experiment fatigue FIVE fixed food group groups highlighting Impact information measure Metrics Mobile Older outcome phone survey Primary outcome question Randomized Randomly reported respondent response response fatigue. score secondary survey trade-off Volume were assessed women [DOI] 10.1093/jn/nxac153 PMC 바로가기
Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in JapanArticle Published on 2022-10-052022-11-16 Journal: Medicina [Category] COVID19(2023년), SARS, 변종, [키워드] 113 patient and post COVID-19 condition caused change changes in Characteristics characterized cough COVID COVID patient COVID-19 delta variant dysgeusia dysosmia fatigue Frequency hospitalizations illnesses Insomnia Japan Long manifestation material Myalgic encephalomyelitis/chronic fatigue syndrome objective omicron Omicron variant outpatient clinic Patient patients prevalent Result retrospective significantly significantly lower single-center Symptom syndrome the patient three groups university vaccination variant variants viral variant were infected [DOI] 10.3390/medicina58101393 PMC 바로가기
Assessing the mechanism of citywide test-trace-isolate Zero-COVID policy and exit strategy of COVID-19 pandemicArticle Published on 2022-10-042022-11-15 Journal: Infectious Diseases of Poverty [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] 95% confidence interval Assessing Asymptomatic benefit calibration China Citywide testing coefficient compartmental model Compliance conducted Contact tracing contagious contribute COVID case COVID-19 COVID-19 pandemic deaths Delta develop Effectiveness eliminating Evolution exit Exit strategy fatigue implementation infections Isolation Latin Measures mechanism new strain omicron outbreak Outbreaks Partial PRCC projection proportion public health question raised RANK Region resource resources sensitivity analysis supported Test-trace-isolate the epidemic the SARS-CoV-2 Transmission Transmission model vaccination variant Zero-COVID policy. [DOI] 10.1186/s40249-022-01030-7 PMC 바로가기
Aseptic meningitis in multisystem inflammatory syndrome in children associated with coronavirus disease 2019: a case reportArticle Published on 2022-10-042022-11-15 Journal: Journal of Medical Case Reports [Category] COVID19(2023년), SARS, 진단, [키워드] abdominal pain Aseptic aseptic meningitis C-reactive protein capillary blood Case report case sery children clinical manifestations coronavirus disease Corticosteroid COVID COVID 19 Deterioration Diagnosis early treatment effective Electrolyte elevated erythrocyte sedimentation rate fatigue Fever functions headache immune response Immunoglobulin Infection Inflammatory inflammatory markers intensive care Intravenous immunoglobulin laboratory result Leukocytosis life-threatening lymphopenia male manifestation Manifestations Meningitis Methylprednisolone MIS-C mononuclear cell Multiorgan dysfunction neurological manifestation Neurological symptoms obesity organ dysfunction pediatric polymorphonuclear procalcitonin renal syndrome vomiting White blood cell [DOI] 10.1186/s13256-022-03617-y PMC 바로가기
Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance studyArticle Published on 2022-10-032022-11-15 Journal: Revista do Instituto de Medicina Tropical de São [Category] 진단, [키워드] Active surveillance Administered advanced age Adverse adverse event Brazil center chronic conditions collected Comorbidities Contact CoronaVac COVID-19 vaccine daily living dose doses eight enrolled evaluate event fatigue female frailty headache Healthcare workers home immunization impairment inactivated Inactivated vaccine information injection Mild moderate MOST myalgia participant Population public health receive reference reported Safe severe adverse events team the vaccine vaccination vaccination schedule Vaccine vaccine dose virus with COVID-19 [DOI] 10.1590/S1678-9946202264056 PMC 바로가기